BOLNO PAUL 4
4 · Wave Life Sciences Ltd. · Filed Nov 27, 2024
Insider Transaction Report
Form 4
BOLNO PAUL
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Ordinary Shares
2024-11-25$2.48/sh+50,000$124,000→ 267,351 total - Exercise/Conversion
Share Option (right to buy)
2024-11-25−50,000→ 47,778 totalExercise: $2.48Exp: 2025-03-10→ Ordinary Shares (50,000 underlying) - Sale
Ordinary Shares
2024-11-25$15.00/sh−50,000$750,000→ 217,351 total
Footnotes (2)
- [F1]The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024.
- [F2]These share options are fully vested.